Monitoring EDTA and endogenous metabolite biomarkers from serum with mass spectrometry

11Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We describe a quantitative method for the determination of ethylenediaminetetraacetic acid (EDTA) in human serum by gas chromatography mass spectrometry (GC-MS), liquid chromatography electrospray ionisation tandem mass spectrometry (LC-ESI-MS/MS), and desorption ionisation on silicon mass spectrometry (DIOS-MS). In the initial stages of the analysis, endogenous metabolites (1-palmitoyl-sn-glycero-3-phosphocholine and 1-stearoyl-sn-glycero- 3-phosphocholine) were readily observed in LC-ESI-MS and DIOS-MS however, direct analysis of the EDTA free acid had limited sensitivity. In order to improve EDTA detection we employed a straightforward esterification derivatization. The most successful derivatization procedure converted EDTA to its methyl ester and, since 13C isotopes of these reagents are readily available, internal standards could be easily generated for quantitative analysis. This approach provided a limit of detection of 0.5 and 0.1 μM for GC-MS and LC-ESI-MS, and offers a viable method for the EDTA detection. © 2005 - IOS Press and the authors. All rights reserved.

Cite

CITATION STYLE

APA

Lowe, R., Go, E. P., Tong, G. C., Voelcker, N. H., & Siuzdak, G. (2005). Monitoring EDTA and endogenous metabolite biomarkers from serum with mass spectrometry. Spectroscopy, 19(3), 137–146. https://doi.org/10.1155/2005/428672

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free